The impact of endocrine therapy on patients with breast cancer: a review of the literature

This publication has 52 references indexed in Scilit:

• Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment
  European Journal Of Cancer, 1999
• Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?
  European Journal Of Cancer, 1999
• Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
  The Lancet, 1998
• Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women
  The Lancet, 1998
• New endocrine therapies for breast cancer
  European Journal Of Cancer, 1996
• A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *
  European Journal Of Cancer, 1996
• A Risk-Benefit Assessment of Tamoxifen Therapy
  Drug Safety, 1993
• The MOS 36-ltem Short-Form Health Survey (SF-36)
  Medical Care, 1992
• The Hospital Anxiety and Depression Scale
  Acta Psychiatrica Scandinavica, 1983
• The CES-D Scale
  Applied Psychological Measurement, 1977